Jianxin Biotech Stock

Jianxin Bio focuses on new monoclonal antibody drugs, CAR-T (Chimeric Antigen Receptor T Cell) technology innovation.

Sign up today and learn more about Jianxin Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Jianxin Biotech Stock

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: